Kidman and Duitch to discuss how cutting-edge delivery system technology will revolutionize the beauty industry
Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), announced today that Academy Award, Golden Globe and Emmy Award-winning actor/producer/entrepreneur Nicole Kidman and Sera Labs CEO/CURE Pharmaceutical Chief Strategic Officer, Nancy Duitch will headline Collision 2021. Collision is North America’s fastest-growing tech conference and brings together the world’s most sought-after founders, tech companies, and game-changing entrepreneurs of our time.
Sera Labs and CURE Pharmaceutical have the technology and are poised to set the new standard that will change how the world utilizes beauty, health and wellness products. Kidman and Duitch will discuss how cutting-edge delivery system technology, over a decade’s worth of research and development, seventeen published patents, and extensive expertise in proprietary encapsulation and polymer methodologies, which are fused into Sera Labs’ anti-aging beauty, health and wellness products, will demand attention and accomplish this beauty revolution.
“Speaking with Nicole at Collision is a milestone moment for the brand. Science and technology have always been cornerstones for our company success. The world watches what happens at Collision. We are excited to be there and share more about our cutting-edge anti-aging beauty technology,” said Duitch, Sera Labs CEO/Founder and CURE Pharmaceutical Chief Strategic Officer.
Collision will take place virtually on its proprietary software from April 20-22, 2021, and is expected to attract over 40,000 attendees from over 100 countries. To learn more about the Collision Conference, visit https://collisionconf.com/. Kidman and Duitch will be headlining day two of the conference.
About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com, seralabshealth.com and follow us on Instagram at @seratopical, as well as Twitter, and Facebook. Media contact: firstname.lastname@example.org.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005490/en/
Monica M. Jaramillo, LABEL the Agency
Investor and Corporate Relations:
Kathryn Brown, CMW